Italian health ministry seeks damages of $1.6 billion for Novartis and Roche collusion

The damages follow a March guilty verdict that the companies inflated the price of Lucentis

Major Swiss pharmaceutical companies Novartis and Roche were fined a combined $250 million for drug collusion in March, but if Italy’s health ministry has its way, the actual price will be much, much higher.

On May 28, the health ministry announced that it will seek damages of €1.2 billion ($1.6 billion) from the two companies for working together to push the cost of the jointly-marketed drug Lucentis higher. In a statement, the health ministry said that this move is a result of Novartis and Roche had causing “considerable damage” to Italian citizens through their actions.

Executive Editor

author image

Chris DiMarco

Chris DiMarco, Executive Editor of InsideCounsel magazine, has a background in multimedia production with previous involvement in projects in which he developed and created content...

Bio and more articles

Join the Conversation

Advertisement. Closing in 15 seconds.